Carnegie has published a new commissioned research report initiating coverage on
To access the full report and subscribe to future updates, visit https://www.carnegie.se/en/commissioned-research/eql-pharma/
© Modular Finance, source
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
43.3 SEK | +0.46% | +2.85% | +29.64% |
May. 15 | Transcript : EQL Pharma AB, Q4 2024 Earnings Call, May 15, 2024 | |
May. 14 | Eql Pharma AB Provides Sales Guidance for the Year 2024/25 | CI |
Carnegie has published a new commissioned research report initiating coverage on
To access the full report and subscribe to future updates, visit https://www.carnegie.se/en/commissioned-research/eql-pharma/
© Modular Finance, source
1st Jan change | Capi. | |
---|---|---|
+29.64% | 118M | |
-31.29% | 15.68B | |
-20.59% | 12.39B | |
-21.23% | 6.74B | |
-6.15% | 6.29B | |
+10.76% | 6.26B | |
+70.00% | 4.95B | |
-2.48% | 4.66B | |
-5.58% | 4.03B | |
-9.24% | 3.62B |